‘.. Lead study author Dr. Gillian Smith of the University of Dundee, said:’these results highlight additional gene error that might be tested in cancer. Determine which. People respond best to the drug – ‘The next stage is an effective test for screening for this mutation ‘hotspots’ plan doctors plan the most effective treatment strategies for colorectal cancer patients and develop – and this will encourage scientists also focus its efforts on the development of new therapies for patients with defective K – Ras genes to give them more options ‘ – Lesley Walker Lesley Walker.
Reference? ‘Activating KRAS mutations outside hotspot codons in sporadic colorectal tumors – implications for personalized cancer medicine ‘Smith, British Journal of Cancer DOI: 10.6605534NotescetuximabCetuximab is currently available on the NHS as one of several treatment options in the specific cases where patients cancer that has spread to the liver and where shrinkage of secondary cancer with chemotherapy can potentially allow an operation to remove – which may be the cancer patients treated successfully. Wide coverage is planned, a number of different cancer treatment options than the maximum reached reached. Continue reading